Search Results 411-420 of 17527 for ulcerative colitis

  1. Ileoanal anastomosis (J-pouch) surgery - Doctors & Departments - Mayo Clinic

    This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

  2. Conner's story: sharing family history and genetic testing lead to better health for young boy and his father - Mayo Clinic News Network

    She urged her grandson and his family to turn to Mayo Clinic for answers. At Mayo, Conner was diagnosed with ulcerative colitis, an inflammatory bowel disease ...

  3. Ileoanal anastomosis (J-pouch) surgery - Doctors & Departments - Mayo Clinic

    This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

  4. Polyethylene glycol 3350 and electrolytes (oral route) - Mayo Clinic

    Ulcerative colitis, active and severe—Use with caution. May make these ... This medicine may cause serious bowel problems (eg, colon ulcers, ischemic colitis).

  5. Ustekinumab-kfce (intravenous route, subcutaneous route) - Mayo Clinic

    Ustekinumab-kfce injection is also used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

  6. Collection of Blood in Patients with Inflammatory Bowel Disease - Mayo Clinic

    Inflammatory bowel disease (IBD) is defined as Crohn's Disease (CD), Ulcerative Colitis (UC), Indeterminate Colitis (IC) and IBD, type not specified. At ...

  7. Kellie L. Mathis, M.D. - Doctors and Medical Staff - Mayo Clinic

    Inflammatory Bowel disease including: indeterminate colitis, ulcerative colitis, and Crohn's disease; Polyposis syndromes and inflammatory bowel disease ...

  8. Adalimumab-aacf (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-aacf injection is also used to treat moderate to severe Crohn's disease. It is also used to treat moderate to severe ulcerative colitis in patients ...

  9. Colonoscopy Clinical Trials - Mayo Clinic Research

    ... Ulcerative Colitis Rochester, MN. This study comprises three sub-studies. The objective of sub-study 1 was to characterize the dose-response, efficacy, and ...

  10. Shabana F. Pasha, M.D. - Mayo Clinic Faculty Profiles

    She also has an interest in biomarker discovery for Crohn's disease and ulcerative colitis, as well as new therapies for eosinophilic esophagitis. Focus ...